InvestorsHub Logo
Followers 139
Posts 23252
Boards Moderated 0
Alias Born 04/08/2004

Re: kevli33 post# 186843

Monday, 03/25/2019 10:47:40 PM

Monday, March 25, 2019 10:47:40 PM

Post# of 463637
Anavex could give the Japanese market to Eisai in exchange for Eisai paying for all of the FDA and EMA trial costs and Anavex getting the RoW (Rest of World) market including the USA and Europe and the rest of Asia, etc. and royalties from sales in Japan.

Alzheimer's and Dementia in Japan. In Japan more 4.6 million people are living with dementia. And this number is expected to rise significantly as the population ages.



https://www.alz.org/jp/dementia-alzheimers-japan.asp

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News